| Literature DB >> 33749896 |
Riccardo Rizzo1,2, Domenico Russo1, Kazuo Kurokawa3, Pranoy Sahu1, Bernadette Lombardi1, Domenico Supino1, Mikhail A Zhukovsky1, Anthony Vocat4, Prathyush Pothukuchi1, Vidya Kunnathully1, Laura Capolupo4, Gaelle Boncompain5, Carlo Vitagliano6, Federica Zito Marino6, Gabriella Aquino6, Daniela Montariello1, Petra Henklein7, Luigi Mandrich1, Gerardo Botti6, Henrik Clausen8, Ulla Mandel8, Toshiyuki Yamaji9, Kentaro Hanada9, Alfredo Budillon6, Franck Perez5, Seetharaman Parashuraman1, Yusuf A Hannun10, Akihiko Nakano3, Daniela Corda1, Giovanni D'Angelo1,4, Alberto Luini1.
Abstract
Glycosphingolipids are important components of the plasma membrane where they modulate the activities of membrane proteins including signalling receptors. Glycosphingolipid synthesis relies on competing reactions catalysed by Golgi-resident enzymes during the passage of substrates through the Golgi cisternae. The glycosphingolipid metabolic output is determined by the position and levels of the enzymes within the Golgi stack, but the mechanisms that coordinate the intra-Golgi localisation of the enzymes are poorly understood. Here, we show that a group of sequentially-acting enzymes operating at the branchpoint among glycosphingolipid synthetic pathways binds the Golgi-localised oncoprotein GOLPH3. GOLPH3 sorts these enzymes into vesicles for intra-Golgi retro-transport, acting as a component of the cisternal maturation mechanism. Through these effects, GOLPH3 controls the sub-Golgi localisation and the lysosomal degradation rate of specific enzymes. Increased GOLPH3 levels, as those observed in tumours, alter glycosphingolipid synthesis and plasma membrane composition thereby promoting mitogenic signalling and cell proliferation. These data have medical implications as they outline a novel oncogenic mechanism of action for GOLPH3 based on glycosphingolipid metabolism.Entities:
Keywords: GOLPH3; Golgi; Trafficking; cisternal maturation; mTOR
Mesh:
Substances:
Year: 2021 PMID: 33749896 PMCID: PMC8047446 DOI: 10.15252/embj.2020107238
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598